Two scientists made huge bets on 'impossible' cancer treatments. They're finally paying off.
Greg Verdine at Revolution Medicines and Tal Zaks at Moderna pushed biotech boundaries with risky, groundbreaking cancer experiments.
Two scientists, Greg Verdine and Tal Zaks, made bold bets on seemingly impossible cancer treatments. Their risky experiments have now paid off, with Moderna's melanoma trial and Revolution Medicines' new drug for late-stage prostate cancer bringing in significant cash for investors. These breakthroughs have been hailed as paradigm shifts in cancer treatment.
Written by urgent.news from Business Insider's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
